在单极性和双极性抑郁症中,对子前带状皮质的高场成像
Frederik Buchholz1, Martin Meffert1, Pierre-Louis Bazin2
1Department of Psychiatry and Psychotherapy, University Hospital Leipzig, Leipzig, Germany.
Frontiers in psychiatry
|October 28, 2024
概括
患有重度抑郁症和双极性障碍的患者在阴前皮层 (sgACC) 的灰质体积减少. 这一发现是在高分辨率7TMRI研究中观察到的,表明sgACC体积作为情感障碍的潜在生物标志物.
科学领域:
- 神经成像是一种神经成像.
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
背景情况:
- 下阴前皮层 (sgACC) 对于情绪调节至关重要.
- 以前的研究表明,sgACC在重大抑郁障碍 (MDD) 和双极性障碍 (BD) 中发生变化.
- 这些变化表明了情绪障碍的潜在生物标志物特征.
研究的目的:
- 为了研究MDD和BD患者的前皮带 (sgACC) 阴茎下灰质体积.
- 为了比较药物治疗/无药物治疗MDD患者,药物治疗BD患者和健康对照患者之间的sgACC体积.
- 建立一种可靠的方法来测量sgACC灰色物质体积.
主要方法:
- 使用高分辨率的7特斯拉磁共振成像 (MRI) 与定量T1地图.
- 开发了一种用于灰质 (GM) 体积分析的半自动细分协议.
- 由两个独立评级机构手动追踪的sgACC感兴趣的区域 (ROI) 具有高度的评级机构间可靠性.
主要成果:
- 药物治疗 (MDDm) 和非药物治疗 (MDDu) 的MDD组与健康对照组相比,左侧sgACC体积显着较小.
- 没有药物治疗的MDD (MDDu) 和双极性障碍 (BD) 组的右侧sgaACC体积明显小于健康对照组.
- 在MDD和BD患者组中证实SgACC灰质体积的减少.
结论:
- 这是第一个使用高分辨率7TMRI的T1地图进行的形态学MRI研究,用于将MDD和BD患者与对照患者进行比较.
- 这些发现突出显示,SgACC灰质体积的减少是MDD和BD的一个特征.
- sgACC灰质体积可以作为情绪障碍的潜在成像生物标志物.
更多相关视频
相关概念视频
Depression: Overview
222
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
222
Brain Imaging
212
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
212


